Keyphrases
Acute Kidney Injury
5%
Acute Pancreatitis
10%
Adverse Effects
12%
Adverse Events
10%
All-cause Mortality
11%
Analytic Study
7%
APACHE II
6%
Assessment Questionnaire
7%
Atrial Fibrillation
7%
Autoimmune Hepatitis
7%
Azithromycin
6%
BISAP
7%
Cardiovascular Disease
7%
Caribbean
17%
Chloroquine
7%
Clinical Outcomes
16%
Clinical Practice Guidelines
7%
Colchicine
7%
Confidence Interval
58%
COVID-19
57%
COVID-19 Pandemic
13%
COVID-19 Patients
12%
Dyspepsia
7%
Early Prediction
7%
Embase
5%
Endoscopy
6%
Expert Panel
11%
Gastric mucosa
5%
Gastrointestinal Endoscopy
7%
Helicobacter Pylori (H. pylori)
16%
Helicobacter Pylori Eradication
10%
Helicobacter Pylori Infection
7%
Hepatitis E
7%
High Risk
7%
Hospitalization
6%
Hospitalized COVID-19 Patients
8%
Hydroxychloroquine
21%
Intention to Vaccinate
8%
Inverse Variance
6%
Latin America (LATAM)
21%
Lima
7%
Lipid Profile
5%
Lipids
11%
Lipoproteins
5%
Lopinavir
7%
Medications for Opioid Use Disorder
7%
Meta-analysis
88%
Meta-analysis of Randomized Controlled Trials
21%
Mitigation Strategies
5%
Network Meta-analysis
7%
Neurological Outcome
5%
Non-ulcer Dyspepsia
10%
Odds Ratio
12%
Older Adults
7%
Peru
37%
Peruvian
20%
Pharmacological Therapy
7%
Placebo
8%
Position Paper
10%
Prevalence Ratio
13%
Primary Gastric Choriocarcinoma
7%
PubMed
6%
Random Effects Model
8%
Randomized Controlled Trial
31%
Relative Risk
5%
Risk of Bias
8%
Risk Ratio
8%
Satisfaction Degree
5%
Severity Prediction
7%
Social Security
7%
Statin Intolerance
5%
Strength of Evidence
5%
Stroke Risk
5%
Symptom Severity
8%
Symptomatology
5%
Systematic Meta-analysis
100%
Triple Therapy
7%
Upper Gastrointestinal Bleeding
12%
Urea
5%
Vaccination
6%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
7%
Acute Kidney Failure
7%
Adverse Event
24%
All Cause Mortality
16%
Bacterial Endocarditis
7%
Bleeding
5%
Cardiovascular Disease
8%
Cardiovascular Mortality
5%
Cardiovascular Risk
7%
Cohort Study
5%
Colchicine
7%
Coronary Artery Disease
11%
Coronavirinae
32%
Dalteparin
7%
Disease
36%
Dyspepsia
10%
Heart Infarction
9%
Helicobacter Infection
6%
Helicobacter Pylori
14%
Hydroxychloroquine
21%
Infection
17%
Ivermectin
7%
Lopinavir Plus Ritonavir
7%
Malignant Neoplasm
10%
Nonalcoholic Fatty Liver
7%
Nutraceutical
7%
Obesity
7%
Observational Study
11%
Pandemic
5%
Placebo
8%
Prevalence
21%
Random Effects Model
10%
Randomized Clinical Trial
5%
Randomized Controlled Trial
56%
SARS Coronavirus
5%
Sepsis
8%
Statin (Protein)
8%
Symptom
18%
Ulcer
10%
Medicine and Dentistry
Acute Kidney Injury
5%
Adverse Event
12%
All Cause Mortality
6%
Apixaban
7%
Apoplexy
11%
Artificial Respiration
6%
Atrial Fibrillation
7%
Biopsy
11%
Cardiovascular Disease
5%
Choriocarcinoma
7%
Cohort Analysis
8%
Coronavirinae
5%
COVID-19
24%
Dalteparin Sodium
7%
Disease
7%
Dyspepsia
7%
Endoscopy
6%
Epigastric Pain
5%
Gastrointestinal Endoscopy
7%
Helicobacter Infection
5%
Helicobacter Pylori
10%
Infection
6%
Ivermectin
7%
Kidney Denervation
7%
Major Bleeding
8%
Melena
5%
Meta-Analysis
64%
Neoplasm
20%
Network Meta-Analysis
5%
Percutaneous Coronary Intervention
6%
Placebo
5%
Prevalence
17%
Randomized Clinical Trial
7%
Randomized Controlled Trial
19%
Symptom
9%
Systematic Review
65%
Ulcer
7%
Upper Gastrointestinal Bleeding
8%
Venous Thromboembolism
7%